Status:
COMPLETED
Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
Novartis Pharmaceuticals
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.
Detailed Description
The study is a clinic-based study with remote patient monitoring that uses a team based intervention composed of community health worker (CHW), nurse (RN), pharmacist, and social worker (SW). Eligible...
Eligibility Criteria
Inclusion
- African American and/or Latinx self-identifying
- Stage II hypertension (140/90) or greater
- Following with Rush primary care provider in eligible Rush primary care clinic
- Access to phone or device with video capabilities in the home
Exclusion
- Dialysis patient
- Organ transplant recipient
Key Trial Info
Start Date :
September 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 12 2025
Estimated Enrollment :
445 Patients enrolled
Trial Details
Trial ID
NCT06027905
Start Date
September 13 2023
End Date
May 12 2025
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612